ArticlePloS one2026
Network-constrained Random Lasso for biologically interpretable gene network inference across unequal sample sizes.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene regulatory network inference is a key approach for elucidating molecular mechanisms underlying complex diseases, but accurately inferring them from high-dimensional data, especially when sample sizes are imbalanced, remains a significant challenge. Although the L1-type regularization methods have been used for gene network inference, the existing methods often fail under conditions involving high dimensionality, noise, and unequal sample sizes across phenotypes. To overcome these limitations, this study developed netRL, a novel computational framework that integrates the Random Lasso with prior network biological knowledge. The proposed method leveraged a bootstrap-based strategy to stabilize the selection of key regulatory genes and incorporates network-informed penalization using centrality measures (i.e., hubness and betweenness centrality). This study also introduced a statistical strategy using a hypergeometric test to assess the significance of the inferred edges, thereby enhancing the reliability of the network. Through extensive simulation studies, this study demonstrated that netRL outperforms conventional methods in both network estimation and gene selection. Applying netRL to whole-blood RNA-seq profiles from the Japan COVID-19 Task Force, this study successfully identified distinct phenotype-specific molecular interplays between asymptomatic and critical cases despite pronounced sample imbalance. The findings reveal that asymptomatic networks were dense and enriched for ribosomal proteins, whereas critical networks were sparse, centralized, and characterized by hub genes such as NFKBIA, B2M, CXCL8, and FOS. Pathway enrichment further revealed phenotype-specific biological processes, highlighting molecular signatures of disease progression. The results of this study suggest that enhancing the activity of asymptomatic condition-specific markers (e.g., ribosomal proteins) may provide important insights into the molecular mechanisms underlying COVID-19 severity. Collectively, these results demonstrate that netRL enables biologically interpretable and statistically robust network inference, offering new insights into the molecular basis of COVID-19 severity and broader applications in systems biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.